+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Chemotherapy-induced thrombocytopenia (CIT) - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy-induced thrombocytopenia (CIT) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cholangiocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cholangiocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
From
Relapsed/refractory acute myeloid leukemia (AML) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed/refractory acute myeloid leukemia (AML) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Relapsing Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsing Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Renal cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Renal cell carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rhabdomyosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Rhabdomyosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Larynx Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Larynx Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Leiomyosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Leiomyosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nasopharyngeal Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Nasopharyngeal Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Neurofibrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Recurrent Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anus Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Anus Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Basal Cell Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Basal Cell Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bile Duct Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Bile Duct Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Biliary Tract Cancer (BTC) - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tract Cancer (BTC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Bladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Bladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more